Vaxxinity Inc. (VAXX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Vaxxinity Inc.

    OTC: VAXX · Real-Time Price · USD
    0.05
    0.02 (99.60%)
    At close: Mar 26, 2025, 2:50 PM

    Vaxxinity Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a 66K
    Cost of Revenue
    		 2.23M 1.68M 1.94M
    Gross Profit
    		 -2.23M -1.68M -1.87M
    Operating Income
    		 -58.28M -75.98M -125.08M
    Interest Income
    		 2.09M 1.26M 9K
    Pretax Income
    		 -56.93K -75.22M -137.18M
    Net Income
    		 -56.93K -75.21M -138.01M
    Selling & General & Admin
    		 22.39M 28.35M 51.83M
    Research & Development
    		 33.66M 47.63M 71.38M
    Other Expenses
    		 n/a n/a -8.37M
    Operating Expenses
    		 56.05M 75.98M 123.2M
    Interest Expense
    		 696K 514K 840K
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 58.28M 75.98M 125.14M
    Income Tax Expense
    		 -56.93K -12K 840K
    Shares Outstanding (Basic)
    		 126.51K 125.94M 125.39M
    Shares Outstanding (Diluted)
    		 126.51K 125.94M 125.39M
    EPS (Basic)
    		 -0.45 -0.6 -1.1
    EPS (Diluted)
    		 -0.45 -0.6 -1.1
    EBITDA
    		 -56.05K -74.3M -135.23M
    EBIT
    		 639.07K -74.71M -136.34M
    Depreciation & Amortization
    		 2.23K 1.68M 1.1M

    Add to Watchlist